← Eichor
Study identifier: NCT02801253 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cohort of Prosthetic Joint Infections

Condition: Prosthetic Joint Infection  ·  Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon

PhaseN/A
Planned participants800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Management of prosthetic joint infections (PJI) is a challenging task. These infections include different clinical and microbiological settings calling upon various treatment strategies according to infection type (acute or chronic), bone quality, the involved micro-organism and the patient's general condition and willing. Treatment of PJI combines surgery and prolonged antibiotic therapy. In some patients with a high operative risk prolonged suppressive antibiotic therapy can be used. Lack of large prospective studies motivated the conception of this cohort with a long term follow up, regardless to PJI management procedures.

This description comes directly from the study's public registry record.

Talk to the study team

YOUNES KERROUMI, Doctorate  ·  (+33) 1 64 44 33 84  ·  ykerroumi@hopital-dcss.org

Always discuss trial participation with your own doctor first.

Locations (1)

Groupe Hospitalier Diaconesses Croix Saint SimonParis, Île-de-France Region, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02801253